Celularity Inc — Form 8-K
Filed August 7, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Celularity filed an 8-K on August 7, 2026 reporting Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing header references these items but the actual text content with specific names, amounts, dates, or details is not provided in the document excerpt. No concrete information about counterparties, dollar figures, share counts, or what specifically changed is available from this submission.
Why this rating
Item 5.02 filings are routine; without disclosed specifics (names, amounts, terms), cannot assess materiality. Company scale $28.4M limits impact even if significant officer change occurred.
Extracted items
See more from August 7, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.